Background The prognostic utility of circulating tumor DNA (ctDNA) for minimal residual disease detection in human papillomavirus (HPV)-negative head and neck squamous cell carcinoma (HNSCC) remains incompletely characterized. This meta-analysis evaluates the association between post-operative ctDNA and recurrence-free...
M. R. Asad, Alejandra Flores Pusarico, Nidhi Reji et al.· Frontiers in Oncology· 0 citations
BACKGROUND
Recurrence after curative-intent treatment remains common in HCC. Circulating tumor DNA (ctDNA) may provide prognostic information, but evidence is heterogeneous.
METHODS
We reviewed 12 cohort studies (880 patients) with HCC treated with curative intent. Associations of preoperative or postoperative ctDNA...
Salah A. Abdelrahim, Reem M. Gahtani, Sameer Alqassimi et al.· Surgical oncology· 0 citations
Nanotechnology has demonstrated transformative potential across molecular diagnostics, targeted drug delivery, and vaccine development; yet the majority of nanoparticle systems that show promise in preclinical settings fail to achieve clinical approval, a translational attrition rate that reflects systematic design g...
A. Ghonaim, Marwa Ahmed El-Naka, W. Nageeb et al.· BMEMat· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.